Vistra Corp vs Viatris Inc — how do they compare? Vistra Corp trades at $162.33 (market cap $53.27B), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: Vistra Corp is far larger — about 2.7× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.83%). Which is the better fit depends on your goals.
| VST | VTRS | |
|---|---|---|
Market Cap | $53.27B | $19.79B |
Sector | Technology | Health |
52-Week High | $217.92 | $17.39 |
52-Week Low | $134.71 | $8.74 |
Enterprise Value | $75.03B | $32.00B |
Dividend Yield | 0.58% | 2.83% |
Trailing returns across standard periods
Latest headlines on both assets
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →